Your browser doesn't support javascript.
loading
Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study.
Carril-Ajuria, Lucia; Desnoyer, Aude; Meylan, Maxime; Dalban, Cécile; Naigeon, Marie; Cassard, Lydie; Vano, Yann; Rioux-Leclercq, Nathalie; Chouaib, Salem; Beuselinck, Benoit; Chabaud, Sylvie; Barros-Monteiro, Janice; Bougoüin, Antoine; Lacroix, Guillaume; Colina-Moreno, Irelka; Tantot, Florence; Boselli, Lisa; De Oliveira, Caroline; Fridman, Wolf Herve; Escudier, Bernard; Sautes-Fridman, Catherine; Albiges, Laurence; Chaput-Gras, Nathalie.
Afiliação
  • Carril-Ajuria L; Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France.
  • Desnoyer A; Laboratory for Immunomonitoring in Oncology, Institut Gustave-Roussy, Villejuif, France.
  • Meylan M; Laboratory for Immunomonitoring in Oncology, Institut Gustave-Roussy, Villejuif, France.
  • Dalban C; Faculté de Pharmacie, Université Paris-Saclay, Chatenay-Malabray, France.
  • Naigeon M; Centre de Recherche des Cordeliers, Inserm UMR S1138, Paris, France.
  • Cassard L; Department of Biostatistics, Centre Leon Bernard, Lyon, France.
  • Vano Y; Faculté de Pharmacie, Université Paris-Saclay, Chatenay-Malabray, France.
  • Rioux-Leclercq N; Laboratoire d'immunomonitoring En Oncologie, Institut Gustave-Roussy, Villejuif, France.
  • Chouaib S; Faculté de Médecine, Université Paris-Saclay, Le Kremlin Bicetre, France.
  • Beuselinck B; Laboratory for Immunomonitoring in Oncology, Institut Gustave-Roussy, Villejuif, France.
  • Chabaud S; Centre de Recherche des Cordeliers, Inserm UMR S1138, Paris, France.
  • Barros-Monteiro J; Service d'Oncologie Medicale, Hopital Europeen Georges Pompidou, Paris, France.
  • Bougoüin A; Service Anatomie Etcytologie Pathologiques, CHU, Université de Rennes, Universite de Rennes 1, Rennes, France.
  • Lacroix G; Department of Immunology, Gustave Roussy Institute, Villejuif, France.
  • Colina-Moreno I; Leuven Cancer Institute, Leuven, Belgium.
  • Tantot F; Department of Biostatistics, Centre Leon Bernard, Lyon, France.
  • Boselli L; Translational Research, UNICANCER, Paris, France.
  • De Oliveira C; Centre de Recherche des Cordeliers, Inserm UMR S1138, Paris, France.
  • Fridman WH; Centre de Recherche des Cordeliers, Inserm UMR S1138, Paris, France.
  • Escudier B; Centre de Recherche des Cordeliers, Inserm UMR S1138, Paris, France.
  • Sautes-Fridman C; GETUG group, Unicancer, Paris, France.
  • Albiges L; Laboratory for Immunomonitoring in Oncology, Institut Gustave-Roussy, Villejuif, France.
  • Chaput-Gras N; Laboratory for Immunomonitoring in Oncology, Institut Gustave-Roussy, Villejuif, France.
J Immunother Cancer ; 10(5)2022 05.
Article em En | MEDLINE | ID: mdl-35640928
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Antineoplásicos Imunológicos / Neoplasias Renais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Antineoplásicos Imunológicos / Neoplasias Renais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França